Post-Market Surveillance (PMS)

What is the PMS process for medical devices?

The Post-Market Surveillance (PMS) process for medical devices is a critical regulatory requirement designed to ensure ongoing safety and effectiveness of devices after they have been marketed. It involves systematically collecting, analyzing, and interpreting data about a device’s performance and adverse events. Manufacturers must develop a comprehensive PMS plan, which includes gathering end-user feedback, monitoring clinical results, and reviewing scientific literature. Issues identified through PMS may lead to corrective actions, such as updating the product, enhancing training, or even recalling a device. Results from PMS activities must be documented and reported to regulatory authorities to comply with legal obligations and support continuous improvement of the device.

What are the responsibilities of post-market surveillance medical devices?

Post-market surveillance (PMS) of medical devices is critical to maintaining patient safety and device efficacy throughout the product lifecycle. The responsibilities involved in PMS include:

• Monitoring and Reporting: Continuously monitor the performance and safety of medical devices after they have been launched. This includes collecting and evaluating data from various sources, such as clinical use reports, feedback from healthcare professionals and patients, and literature reviews.
• Adverse Event Reporting: Systematically capturing, investigating, and reporting adverse events and other incidents to regulatory authorities in compliance with local laws and regulations. This helps identify potential safety issues that may not have been apparent during the pre-market phase.
• Risk Management: Updating the risk management process based on post-market data and experiences to mitigate any emerging risks associated with the device.
• Corrective Actions: Implementing corrective actions when necessary, such as device modifications, recalls, or issuing safety alerts to manage any risks identified during the post-market phase.
• Performance Reviews: The collected data should be reviewed regularly to assess the device’s benefit-risk balance and ensure continued compliance with regulatory requirements.
• Documentation and Reporting: Maintain detailed records of all surveillance activities and report findings to regulatory authorities and other stakeholders as required.

What is an example of post-market surveillance?

An example of post-market surveillance (PMS) involves a manufacturer of cardiac stents. After their stents are released onto the market, the manufacturer actively monitors their performance through various PMS activities. This includes collecting data from hospitals and clinics on the rate of complications such as stent thrombosis or restenosis. They also gather feedback from cardiologists and patients regarding the device's efficacy and any adverse events experienced.

Additionally, the manufacturer regularly reviews scientific literature and participates in clinical registries to compare their stents' performance against others in the market. Based on the outcomes, the manufacturer may update the device's labeling, provide additional training to healthcare providers, or make design modifications. They report these findings and corrective actions to regulatory authorities to ensure compliance and maintain public trust in their product.

What is the difference between pharmacovigilance and post-marketing surveillance?

Pharmacovigilance and post-market surveillance (PMS) are both crucial processes in monitoring the safety and effectiveness of health products after they have been released to the market, but they focus on different types of products and involve distinct activities:

• Pharmacovigilance:

• Scope: Specifically pertains to pharmaceuticals, including prescription drugs, over-the-counter medications, and biologics.
• Purpose: To detect, assess, understand, and prevent adverse effects or other drug-related problems.
• Activities: Collecting and analyzing adverse drug reaction reports from healthcare providers, patients, and other stakeholders. Pharmacovigilance also involves evaluating patient safety data from clinical trials, literature reviews, and databases to identify new information about hazards associated with drug products.

• Post-Market Surveillance (PMS):

• Scope: Broadly applicable to medical devices, from simple devices like bandages to complex technologies like pacemakers.
• Purpose: To ensure ongoing safety and effectiveness of the device across its lifecycle and to detect any potential device-related failures or adverse events.
• Activities: PMS involves collecting data from various sources, including customer feedback, clinical studies, and the analysis of returned products. It may also involve corrective actions such as recalls, safety alerts, or modifications to the device or its labeling.

Both pharmacovigilance and post-market surveillance are integral to regulatory compliance. They are designed to protect public health by ensuring that the benefits of drugs and medical devices continue to outweigh their risks after they reach the market.

ISO 13485 also plays a role in post-marketing surveillance. The standard focuses on ensuring the safety and quality of medical devices throughout their lifecycle.